AR026768A1 - Moleculas similares a antagonistas de receptores de interleukin-1 y usos de las mismas - Google Patents

Moleculas similares a antagonistas de receptores de interleukin-1 y usos de las mismas

Info

Publication number
AR026768A1
AR026768A1 ARP000106550A ARP000106550A AR026768A1 AR 026768 A1 AR026768 A1 AR 026768A1 AR P000106550 A ARP000106550 A AR P000106550A AR P000106550 A ARP000106550 A AR P000106550A AR 026768 A1 AR026768 A1 AR 026768A1
Authority
AR
Argentina
Prior art keywords
interleukin
antagonists
receivers
same
polypeptides similar
Prior art date
Application number
ARP000106550A
Other languages
English (en)
Spanish (es)
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of AR026768A1 publication Critical patent/AR026768A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244Interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/30Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ARP000106550A 1999-12-10 2000-12-11 Moleculas similares a antagonistas de receptores de interleukin-1 y usos de las mismas AR026768A1 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US17019199P 1999-12-10 1999-12-10
US18805300P 2000-03-09 2000-03-09
US19452100P 2000-04-04 2000-04-04
US19591000P 2000-04-10 2000-04-10
US72458300A 2000-11-28 2000-11-28

Publications (1)

Publication Number Publication Date
AR026768A1 true AR026768A1 (es) 2003-02-26

Family

ID=27538813

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000106550A AR026768A1 (es) 1999-12-10 2000-12-11 Moleculas similares a antagonistas de receptores de interleukin-1 y usos de las mismas

Country Status (6)

Country Link
EP (1) EP1246844A1 (ja)
JP (1) JP3842647B2 (ja)
AR (1) AR026768A1 (ja)
AU (1) AU779534B2 (ja)
MX (1) MXPA02005775A (ja)
TW (1) TWI283683B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018106956A2 (en) * 2016-12-07 2018-06-14 University Of Florida Research Foundation, Incorporated IL-1RA CDNAs
CN113940308A (zh) * 2021-04-28 2022-01-18 重庆腾达牧业有限公司 大足黑山羊哺乳舍饲养管理方法

Also Published As

Publication number Publication date
MXPA02005775A (es) 2003-10-14
JP2003518371A (ja) 2003-06-10
JP3842647B2 (ja) 2006-11-08
AU779534B2 (en) 2005-01-27
AU1945001A (en) 2001-06-18
EP1246844A1 (en) 2002-10-09
TWI283683B (en) 2007-07-11

Similar Documents

Publication Publication Date Title
ECSP034772A (es) Antagonistas de mch y su uso en el tratamiento de obesidad
BRPI0413563A (pt) compostos e composições como inibidores de atividade do receptor de quìnase de tirosina
FI963101A (fi) Anti-TNF-vasta-aineiden käyttö lääkkeenä sellaisten sairauksien hoitoon, joissa seerumin interleukiini-6-taso on kohonnut
AR029199A1 (es) Derivados de adenosina n6 heterociclico 5'-tio- sustituidos agonistas a1 parciales o totales, sus usos, y sus composiciones farmaceuticas
BRPI0512674A (pt) compostos e composições como moduladores de receptores nucleares de hormÈnio esteróide
BR0309875A (pt) métodos e composições para tratamento de distúrbios do sistema nervoso periférico e novos compostos úteis para isto
EA200101019A1 (ru) Модуляторы рецепторов глюкокортикоидов
YU83600A (sh) Adenozin a3 receptorski modulatori
AR002705A1 (es) Un nuevo compuesto de indolina, un proceso para su preparacion y composiciones farmaceuticas que lo contienen.
MA29088B1 (fr) Composes d'indazole-carboxamide.
BR0207952A (pt) Moduladores da atividade de receptores de quimiocina
BR0315234A (pt) Derivados de indol como agonistas beta-2
UY24560A1 (es) Derivados arilos de la pirimidina útiles como antagonistas 5ht2b selectivos
AR030236A1 (es) Moléculas similares a il-17 y usos de las mismas
MX9301348A (es) Nuevos compuestos que tienen actividad farmacologica, proceso para su preparacion y composicion farmaceutica que los comprende.
CO6351782A2 (es) COMPUESTOS NOVEDOSOS CON ACTIVIDAD ANTAGONISTA DEL RECEPTOR á 7 NICOTINICO DE ACETILCOLINA
AR030554A1 (es) Moleculas similares a receptores il-17 y usos de las mismas
ES2196063T3 (es) Utilizacion de agentes antagonistas competitivos de progesterona para la preparacion de medicamentos destinados al tratamiento de hemorragias uterinas disfuncionales.
GT200300294A (es) Compuestos de indazol y composiciones farmaceuticas para inhibir proteinquinasas y procedimientos para su uso
WO2005030678A3 (en) AMINO-SUBSTITUTED ETHYLAMINO β2 ADRENERGIC RECEPTOR AGONISTS
BRPI0413013A (pt) composto, seus sais, solvatos, e derivados farmaceuticamente funcionais, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de condições ou distúrbios, e de doenças
CR6581A (es) Pirrolcarboxamidas fundido, receptores cerebrales gaba
ECSP003707A (es) Diazepanes
WO2003087338A3 (en) Her-2 receptor tyrosine kinase molecules and uses thereof
DK1196442T3 (da) VGF-polypeptider og fremgangsmåder til behandling af VGF-relaterede lidelser

Legal Events

Date Code Title Description
FB Suspension of granting procedure